Recent News

• 04.01.2025 - Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
• 04.01.2025 - Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
• 03.31.2025 - Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
• 03.31.2025 - Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
• 03.05.2025 - John Newman, PhD
• 03.05.2025 - John Newman, PhD
• 02.26.2025 - Leah Cann, MBA
• 02.26.2025 - Leah Cann, MBA
• 02.25.2025 - H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
• 02.25.2025 - H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Recent Filings

• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.27.2025 - 8-K Current report
• 03.04.2025 - 8-K/A Current report
• 02.19.2025 - 8-K Current report
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities